What is a significant risk associated with maternal use of cocaine during pregnancy?

Maternal use of cocaine during pregnancy is associated with severe and profound intellectual disabilities and other developmental defects due to the drug's impact on fetal brain development and overall health. Cocaine can lead to a range of adverse outcomes, including growth restrictions, low birth weight, and developmental delays. It can also adversely affect the brain structure and function of the developing baby, leading to long-term cognitive and behavioral issues.

Research indicates that exposure to cocaine in utero can result in a higher likelihood of neurodevelopmental disorders, including learning disabilities and problems with attention and impulse control. These risks are significantly more severe than minor impacts and can lead to lifelong challenges for the child.

Understanding these risks emphasizes the importance of maternal health and the potential consequences of substance use during pregnancy, highlighting the need for preventive measures and support for expectant mothers.